Table 1.
Univariate analysis of pretreatment variables
| Variable |
Patients |
Survival time (%) |
Median survival length (mo) | P value | ||
| n (%) | 1 yr | 5 yr | 10 yr | |||
| Age (yr) | ||||||
| ≤ 50 | 848 (54.0) | 46 | 9 | 7 | 9.63 | 0.003 |
| > 50 | 721 (46.0) | 49 | 11 | 7 | 11.60 | - |
| HBV | ||||||
| HBsAg(-)HBeAg(-) | 215 (13.8) | 55 | 15 | 12 | 13.70 | 0.000 |
| HBsAg(+)HBeAg(-) | 811 (52.2) | 50 | 11 | 9 | 11.43 | - |
| HBsAg(+)HBeAg(+) | 529 (34.0) | 40 | 7 | 3 | 8.27 | - |
| AFP (ng/mL) | ||||||
| ≤ 20 | 292 (19.0) | 61 | 18 | - | 15.80 | 0.000 |
| 21-200 | 296 (19.3) | 56 | 13 | 9 | 13.50 | - |
| > 200 | 946 (61.7) | 41 | 7 | 6 | 8.53 | - |
| Child-Pugh grade | ||||||
| A | 1413 (90.8) | 49 | 11 | 8 | 10.97 | 0.000 |
| B | 144 (9.2) | 34 | 6 | 4 | 6.40 | - |
| Nodules | ||||||
| ≤ 3 | 855 (54.5) | 52 | 12 | 8 | 12.30 | 0.000 |
| > 3 | 714 (45.5) | 42 | 8 | - | 8.57 | - |
| Greatest dimension (cm) | ||||||
| ≤ 5.0 | 164 (10.5) | 71 | 25 | 16 | 19.03 | 0.000 |
| 5.1-10 | 624 (39.8) | 50 | 11 | 6 | 11.77 | - |
| 10.1-15 | 606 (38.6) | 43 | 8 | 7 | 9.10 | - |
| > 15 | 175 (11.2) | 29 | 3 | - | 6.10 | - |
| Tumor capsule | ||||||
| No | 818 (52.8) | 41 | 9 | 5 | 8.40 | 0.000 |
| Yes | 732 (47.2) | 55 | 11 | 9 | 12.50 | - |
| Macrovascular invasion | ||||||
| No | 1276 (81.3) | 50 | 12 | 8 | 11.70 | 0.000 |
| Yes | 293 (18.7) | 34 | 3 | - | 7.10 | - |
| Regional lymph node metastasis | ||||||
| No | 1519 (96.8) | 48 | 10 | 7 | 10.50 | 0.032 |
| Yes | 50 (3.2) | 31 | 8 | - | 7.10 | - |
| Distant metastasis | ||||||
| No | 1302 (82.9) | 48 | 12 | 8 | 10.40 | 0.183 |
| Yes | 269 (17.1) | 46 | 4 | - | 10.13 | - |